Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now discovered a molecular-level resistance mechanism that begins to take hold as early as six to eight weeks after the cancer drug is introduced. They report their findings in Nature Structural & Molecular Biology.
Continue Reading this article here
